Mining a large database of adverse reactions to medications, UC San Diego researchers found that people who took proton pump inhibitors (e.g., Prilosec, Nexium) for heartburn and acid reflux were more likely to experience kidney disease than people who took other forms of antacid.
University of California San Diego, in a collaborative agreement with Leica Microsystems, Inc., hosted a signing ceremony to inaugurate a new Leica Microsystems Center of Excellence on the School of Medicine campus.
An international group that includes researchers at University of California San Diego School of Medicine has identified 124 genetic variants associated with a person’s willingness to take risks, as reported in a study published January 14, 2019 in Nature Genetics.
After living with debilitating phantom leg pain for 18 years, Raul Silva is excited about a new dorsal root ganglion (DRG) stimulation device that erased his pain during a testing phase at UC San Diego Health, one of the only health care providers in the region offering the device.
Researchers spent two years testing chemical compounds for their ability to inhibit the malaria parasite at an earlier stage in its lifecycle than most current drugs, revealing a new set of chemical starting points for the first drugs to prevent malaria instead of just treating the symptoms.
In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs.
Forty-five faculty members at the University of California San Diego are among the world’s most influential researchers in their fields, according to Clarivate Analytics' list of 2018 "Highly Cited Researchers."
A team led by scientists from Scripps Institution of Oceanography at the University of California San Diego and the J. Craig Venter Institute (JCVI) has uncovered the genetic basis for the production of domoic acid, a potent neurotoxin produced by harmful algal blooms.
In a study publishing September 26 in Science Advances, researchers at University of California San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences report that tweaking factors in a cystic fibrosis lung model, such as pH balance and oxygen, helped eradicate…
Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego have now identified three new molecular drug targets in Naegleria fowleri and a number of drugs that are able to inhibit the amoeba’s growth in a laboratory dish. Several of these drugs…